
Trazodone
Trazodone is an approved antidepressant that beat placebo in pooled trials but ranked among the less effective and less tolerated antidepressants in head-to-head studies. It is widely used off-label for sleep, where low-quality trials show a small improvement in how people rate their sleep. For supplement users, the main points are to avoid alcohol and to check 5-HTP, tryptophan and other serotonin products with a pharmacist.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults with major depressive disorder whose prescriber has chosen trazodone
Common dosing range
Set by your prescriber. The label's starting dose is 150 mg a day in divided doses, raised by 50 mg a day every 3 to 4 days, usually to no more than 400 mg a day for outpatients
When to expect effects
Drowsiness can appear with the first doses; antidepressant benefit builds over weeks
Watch out for
Boxed warning for suicidal thoughts in young people. Never combine with an MAOI (including linezolid or intravenous methylene blue) or within 14 days of stopping one. Serotonin syndrome is possible with other serotonin-raising drugs and supplements. It can prolong the QT interval, cause fainting from low blood pressure, raise bleeding risk and, rarely, cause priapism
What is it
Trazodone is a prescription antidepressant taken as a tablet; a newer oral solution is sold as Raldesy. The FDA label approves it for major depressive disorder in adults only, and it is not approved for children. Because it is sedating, doctors also often prescribe low doses off-label for sleep, a use the label does not cover. It has a boxed warning about suicidal thoughts in children and young adults.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
major depressive disorder in adults Good Evidence | Better than placebo; smaller than several other antidepressants in head-to-head trials | Adults with major depression for whom a prescriber judges trazodone suitable, for example when sedation is acceptable | Weeks, as measured in short-term trials |
insomnia, an off-label use (how people rate their sleep) Limited Evidence | Small to moderate improvement in self-rated sleep (SMD -0.34) | Adults with insomnia whose prescriber suggests a short trial | Short-term trials only |
insomnia, measured sleep efficiency in a sleep lab Limited Evidence | No clear difference from placebo | Not applicable | Not applicable |
major depressive disorder in adults
- Effect
- Better than placebo; smaller than several other antidepressants in head-to-head trials
- Best fit
- Adults with major depression for whom a prescriber judges trazodone suitable, for example when sedation is acceptable
- Time
- Weeks, as measured in short-term trials
insomnia, an off-label use (how people rate their sleep)
- Effect
- Small to moderate improvement in self-rated sleep (SMD -0.34)
- Best fit
- Adults with insomnia whose prescriber suggests a short trial
- Time
- Short-term trials only
insomnia, measured sleep efficiency in a sleep lab
- Effect
- No clear difference from placebo
- Best fit
- Not applicable
- Time
- Not applicable
Evidence for 3 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
major depressive disorder in adults
Disease adjunctA 2018 network meta-analysis pooled 522 double-blind trials (116,477 adults) of 21 antidepressants for acute major depression. All of them, including trazodone, were more effective than placebo. In head-to-head trials, trazodone was among the least effective drugs and among those with the highest dropout rates. The authors rated the certainty of evidence moderate to very low, and the trials covered short-term treatment only.
Bottom line: Trazodone treats depression better than placebo but less well than several other antidepressants.
insomnia, an off-label use (how people rate their sleep)
Disease adjunctSleep is not an FDA-labeled use. A 2018 Cochrane review of antidepressants for insomnia pooled 3 small trials of trazodone (370 participants) and found a moderate improvement in how people rated their sleep compared with placebo (SMD -0.34); the reviewers rated the evidence low quality overall. Two trials reported more morning grogginess, dry mouth and thirst with trazodone. The studies were short, and there was no evidence on long-term use.
Bottom line: Trazodone may slightly improve how well people feel they sleep, in short, low-quality trials.
insomnia, measured sleep efficiency in a sleep lab
No benefit foundIn the same Cochrane review, two trazodone trials (169 participants) measured sleep with overnight polysomnography. Sleep efficiency (the share of time in bed spent asleep) was not clearly better than with placebo (mean difference 1.38 percentage points, not significant; low quality evidence).
Bottom line: In sleep-lab measurements, trazodone did not clearly improve sleep efficiency.
How it works
How to take it
What to track
Bottom line: Your prescriber sets the dose; take it after food, avoid alcohol and check every supplement with your pharmacist.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Boxed warning: antidepressants increased suicidal thoughts and behaviors in children and young adults in short-term studies; all patients need close monitoring for worsening and new suicidal thoughts. Trazodone is not approved for children.
Serotonin syndrome, potentially life-threatening, with higher risk alongside triptans, other antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, St. John's wort or MAOIs.
QT prolongation and heart rhythm problems, including torsade de pointes reported at doses of 100 mg or less; risk is higher with existing heart disease, low potassium or magnesium, and other QT-prolonging drugs or strong CYP3A4 blockers.
Low blood pressure on standing and fainting, and a higher bleeding risk, especially with aspirin, NSAIDs, warfarin and other blood thinners.
Priapism (a painful erection lasting more than 6 hours), which can cause permanent damage if not treated quickly; an erection lasting more than 4 hours needs emergency care.
Low blood sodium, angle-closure glaucoma in people with narrow eye angles, mania in people with bipolar disorder, and withdrawal symptoms if stopped suddenly.
Who should avoid it
- People taking an MAOI antidepressant or who stopped one within 14 days, including people being given linezolid or intravenous methylene blue
- People with known QT prolongation or a history of heart rhythm problems (the label says to avoid use), and people in the early recovery phase after a heart attack (not recommended)
- People with untreated narrow eye angles
Pregnancy & breastfeeding
Pregnancy: the label says published studies over several decades have not identified a drug-related risk of major birth defects, miscarriage or other harm to mother or baby, although the studies cannot rule out a risk and had small sizes. Women who stopped antidepressants during pregnancy were more likely to relapse, so talk to your prescriber before making any change, and ask about the National Pregnancy Registry for Antidepressants. Breastfeeding: trazodone passes into breast milk; limited postmarketing reports have not linked it to harm in breastfed babies, and the decision is made with your prescriber.
Interactions
The label lists these as a contraindication because of serotonin syndrome risk. At least 14 days must pass between stopping an MAOI and starting trazodone, and between stopping trazodone and starting an MAOI.
The label says trazodone may enhance the response to alcohol and other sedatives, adding to drowsiness, dizziness and slowed thinking, and deaths from overdose have occurred when trazodone was taken with alcohol and other depressants. The Medication Guide says not to drink alcohol until you talk to your healthcare provider, and not to drive until you know how trazodone affects you.
5-HTP is the body's direct building block for serotonin, so it adds to trazodone's serotonin effect. The label lists tryptophan, the amino acid the body turns into 5-HTP, among products that raise the risk of serotonin syndrome with trazodone; the label does not name 5-HTP itself. Do not combine them unless your prescriber directs it, and seek urgent care for agitation, tremor, sweating, fever or a racing heart.
Strong CYP3A4 blockers raise trazodone levels and the risk of side effects, including heart rhythm problems, and the label says to avoid combining trazodone with other drugs that prolong the QT interval. Your prescriber may lower the dose or choose another medicine.
Drugs that affect serotonin reuptake, including trazodone, raise bleeding risk, and the label says aspirin, NSAIDs, other antiplatelet drugs and anticoagulants may add to it. If you take warfarin, the label asks for careful INR checks when trazodone is started, changed or stopped.
The trazodone label lists St. John's wort among serotonergic products that raise the risk of serotonin syndrome, and also as a CYP3A4 inducer that can lower trazodone levels and weaken its effect. No study of this exact pair has been published. Do not combine them without your prescriber, and if you already take both, ask before stopping either.
Tryptophan is the amino acid the body turns into serotonin, and the trazodone label names it among products that raise the risk of serotonin syndrome; its Medication Guide names it too. No case of serotonin syndrome with this pair has been published. Do not add a tryptophan supplement unless your prescriber advises it, and seek urgent care for agitation, tremor, sweating, fever or a racing heart.
Saffron extract has been tested as an antidepressant in small trials, and its effects may involve serotonin, so in theory it could add to trazodone's serotonin effect. The review cited here looked at saffron's own antidepressant effect, not at saffron taken with trazodone, so whether the two interact is not known. Tell your prescriber if you use a saffron supplement, and watch for agitation, sweating, tremor or a racing heart.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (4)
+ alcohol
highTrazodone and alcohol both depress the central nervous system, producing additive sedation, dizziness, orthostatic hypotension, and impaired coordination. The FDA label states trazodone may enhance the response to alcohol, and combining the two raises the risk of falls and accidents. Rarely, trazodone is associated with QT prolongation, orthostatic syncope, and priapism.
+ 5-htp
highBoth trazodone and 5-HTP raise serotonin activity, but through different routes. Trazodone is a serotonin antagonist and reuptake inhibitor that keeps more serotonin in the synapse, while 5-HTP is a direct precursor that increases how much serotonin the body makes. Stacking the two adds up, and the trazodone label warns of serotonin syndrome when it is combined with other serotonergic drugs, including tryptophan, the precursor of 5-HTP.
+ st. john's wort
highThe trazodone label flags St. John's wort for two reasons. It lists the herb among serotonergic products that raise the risk of serotonin syndrome, a potentially life-threatening reaction, and it lists it as an example of a CYP3A4 inducer, a product that speeds up the liver enzyme that breaks trazodone down and so can lower trazodone levels and weaken its effect. No human study or case report of this exact pair was found; the warning rests on the label, on trazodone being cleared by CYP3A4, and on studies showing St. John's wort speeds up CYP3A4 in healthy volunteers.
+ tryptophan
highTrazodone raises serotonin activity, and L-tryptophan is the amino acid the body turns into serotonin, so taking both can push serotonin activity too high. The trazodone label lists tryptophan among serotonergic products that raise the risk of serotonin syndrome, a potentially life-threatening reaction, and its Medication Guide names tryptophan as an over-the-counter supplement to tell your healthcare provider about. No published case of serotonin syndrome with this pair was found. The only human reports are letters from 1986 to 1989, read by title only: two are titled as describing the combination as a treatment for aggressive behavior, and a 1989 letter is titled as reporting severe anorexia and possible psychosis or hypomania after it.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I take 5-HTP or tryptophan with trazodone?⌄
Not without your prescriber. Both feed the body's serotonin supply, and the trazodone label lists tryptophan among products that raise the risk of serotonin syndrome. Seek urgent care for agitation, tremor, sweating, fever or a racing heart.
Is it safe to drink alcohol with trazodone?⌄
The label says trazodone may enhance the response to alcohol, and deaths from overdose have occurred when it was combined with alcohol and other sedatives. The Medication Guide says not to drink until you talk to your healthcare provider.
Can I drink coffee on trazodone?⌄
Trazodone is not known to slow caffeine breakdown the way fluvoxamine does. The main question is how caffeine affects your sleep and heart rate. Ask your prescriber or pharmacist what amount is reasonable for you.
Is trazodone approved for sleep?⌄
No. The FDA label approves it for major depressive disorder in adults. It is often prescribed off-label for sleep, and a Cochrane review found a small improvement in how people rated their sleep in short, low-quality trials, but no clear change in sleep measured in a sleep lab.
Can I take ibuprofen or aspirin with trazodone?⌄
Ask your pharmacist first. The label says aspirin, NSAIDs such as ibuprofen and blood thinners may add to trazodone's bleeding risk. Tell your prescriber about any regular pain reliever use.
References by claim
major depressive disorder in adults
Cipriani et al., 2018 · PMC (2018) link
insomnia, an off-label use (how people rate their sleep)
Everitt et al., 2018 · PMC (2018) link
Safety
Trazodone hydrochloride tablets prescribing information · DailyMed (FDA label) link
Interaction: Saffron extract
Lopresti et al., 2014 · PubMed (2014) link
Interaction: St. John's wort
Markowitz et al., 2003 · PubMed (2003) link
Track Trazodone with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
